Tiziana Vigo

Genoa, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 18 publications

Corrigendum to "Physical exercise modulates T cell activity and mitigates synaptic dysfunction in multiple sclerosis through vagus nerve engagement" [Brain, Behav., Immun. 135 (2026) 106523, ISSN 0889-1591].

Corrigendum to "Physical exercise modulates T cell activity and mitigates synaptic dysfunction in multiple sclerosis through vagus nerve engagement" [Brain, Behav., Immun. 135 (2026) 106523, ISSN 0889-1591].

Journal: Brain, behavior, and immunity

Published: August 12, 2026

Immunosenescence in multiple sclerosis: New insights and clinical implications.

Immunosenescence in multiple sclerosis: New insights and clinical implications.

Journal: Multiple sclerosis (Houndmills, Basingstoke, England)

Published: September 03, 2025

Physical exercise modulates T cell activity and mitigates synaptic dysfunction in multiple sclerosis through vagus nerve engagement.

Physical exercise modulates T cell activity and mitigates synaptic dysfunction in multiple sclerosis through vagus nerve engagement.

Journal: Brain, behavior, and immunity

Published: August 04, 2025

Noradrenergic control of bone marrow and thymus by AgRP neurons is impaired in experimental multiple sclerosis.

Noradrenergic control of bone marrow and thymus by AgRP neurons is impaired in experimental multiple sclerosis.

Journal: Cell reports

Published: February 26, 2025

JAK2 is a critical therapeutic target in VEXAS syndrome treated with ruxolitinib.

JAK2 is a critical therapeutic target in VEXAS syndrome treated with ruxolitinib.

Journal: British journal of haematology

Published: December 09, 2024

The Human Bone Marrow May Offer an IL-15-Dependent Survival Niche for EOMES+ Tr1-Like Cells.

The Human Bone Marrow May Offer an IL-15-Dependent Survival Niche for EOMES+ Tr1-Like Cells.

Journal: European journal of immunology

Published: November 04, 2024

Study protocol: Exploratory trial of Forza™, an osmotin-based nutraceutical as adjuvant for the treatment of progressive multiple sclerosis.

Study protocol: Exploratory trial of Forza™, an osmotin-based nutraceutical as adjuvant for the treatment of progressive multiple sclerosis.

Journal: PloS one

Published: April 17, 2024

Nerve-Glial antigen 2: unmasking the enigmatic cellular identity in the central nervous system.

Nerve-Glial antigen 2: unmasking the enigmatic cellular identity in the central nervous system.

Journal: Frontiers in immunology

Published: February 29, 2024

COVID-19-associated serum and cerebrospinal fluid cytokines in post- versus para-infectious SARS-CoV-2-related Guillain-Barré syndrome.

COVID-19-associated serum and cerebrospinal fluid cytokines in post- versus para-infectious SARS-CoV-2-related Guillain-Barré syndrome.

Journal: Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology

Published: November 09, 2023

Cerebrospinal fluid NPTX2 changes and relationship with regional brain metabolism metrics across mild cognitive impairment due to Alzheimer's disease.

Cerebrospinal fluid NPTX2 changes and relationship with regional brain metabolism metrics across mild cognitive impairment due to Alzheimer's disease.

Journal: Journal of neurology

Published: November 08, 2023

Longitudinal Cluster Analysis of Hemodialysis Patients with COVID-19 in the Pre-Vaccination Era.

Longitudinal Cluster Analysis of Hemodialysis Patients with COVID-19 in the Pre-Vaccination Era.

Journal: Life (Basel, Switzerland)

Published: September 27, 2022

Neuroprotective Potential of Dendritic Cells and Sirtuins in Multiple Sclerosis.

Neuroprotective Potential of Dendritic Cells and Sirtuins in Multiple Sclerosis.

Journal: International journal of molecular sciences

Published: February 27, 2022

Showing 1-12 of 18

Last Updated: 09/26/2026